The recent finding of SVV-TEM8 binding is of special significance as SVV was initially characterized as an oncolytic virus that selectively kills tumor cells, does not replicate in or kill normal human cells, and has a favorable safety profile in clinical trials (12–15). The gene discussed is ANTXR1; the disease is neoplasm.